Literature DB >> 29263274

The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Cindy Chiang1, Eva-Katharina Pauli2, Jennifer Biryukov3, Katharina F Feister2, Melissa Meng2, Elizabeth A White4, Karl Münger5, Peter M Howley2, Craig Meyers3, Michaela U Gack6,2.   

Abstract

Retinoic acid-inducible gene I (RIG-I) is a key pattern recognition receptor that senses viral RNA and interacts with the mitochondrial adaptor MAVS, triggering a signaling cascade that results in the production of type I interferons (IFNs). This signaling axis is initiated by K63-linked ubiquitination of RIG-I mediated by the E3 ubiquitin ligase TRIM25, which promotes the interaction of RIG-I with MAVS. USP15 was recently identified as an upstream regulator of TRIM25, stabilizing the enzyme through removal of degradative K48-linked polyubiquitin, ultimately promoting RIG-I-dependent cytokine responses. Here, we show that the E6 oncoprotein of human papillomavirus type 16 (HPV16) as well as of other HPV types form a complex with TRIM25 and USP15 in human cells. In the presence of E6, the K48-linked ubiquitination of TRIM25 was markedly increased, and in line with this, TRIM25 degradation was enhanced. Our results further showed that E6 inhibited the TRIM25-mediated K63-linked ubiquitination of RIG-I and its CARD-dependent interaction with MAVS. HPV16 E6, but not E7, suppressed the RIG-I-mediated induction of IFN-β, chemokines, and IFN-stimulated genes (ISGs). Finally, CRISPR-Cas9 gene targeting in human keratinocytes showed that the TRIM25-RIG-I-MAVS triad is important for eliciting an antiviral immune response to HPV16 infection. Our study thus identifies a novel immune escape mechanism that is conserved among different HPV strains and further indicates that the RIG-I signaling pathway plays an important role in the innate immune response to HPV infection.IMPORTANCE Persistent infection and tumorigenesis by HPVs are known to require viral manipulation of a variety of cellular processes, including those involved in innate immune responses. Here, we show that the HPV E6 oncoprotein antagonizes the activation of the cytoplasmic innate immune sensor RIG-I by targeting its upstream regulatory enzymes TRIM25 and USP15. We further show that the RIG-I signaling cascade is important for an antiviral innate immune response to HPV16 infection, providing evidence that RIG-I, whose role in sensing RNA virus infections has been well characterized, also plays a crucial role in the antiviral host response to small DNA viruses of the Papillomaviridae family.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  RIG-I; innate immunity; interferons; papillomavirus

Mesh:

Substances:

Year:  2018        PMID: 29263274      PMCID: PMC5827370          DOI: 10.1128/JVI.01737-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 2.  Mechanisms and strategies of papillomavirus replication.

Authors:  Alison A McBride
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

Review 3.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

4.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.

Authors:  Michael J Conway; Samina Alam; Eric J Ryndock; Linda Cruz; Neil D Christensen; Richard B S Roden; Craig Meyers
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

6.  Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.

Authors:  Michael J Conway; Linda Cruz; Samina Alam; Neil David Christensen; Craig Meyers
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

7.  Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity.

Authors:  Jessica J Chiang; Konstantin M J Sparrer; Michiel van Gent; Charlotte Lässig; Teng Huang; Nikolaus Osterrieder; Karl-Peter Hopfner; Michaela U Gack
Journal:  Nat Immunol       Date:  2017-11-27       Impact factor: 25.606

8.  CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.

Authors:  Ferdy R van Diemen; Elisabeth M Kruse; Marjolein J G Hooykaas; Carlijn E Bruggeling; Anita C Schürch; Petra M van Ham; Saskia M Imhof; Monique Nijhuis; Emmanuel J H J Wiertz; Robert Jan Lebbink
Journal:  PLoS Pathog       Date:  2016-06-30       Impact factor: 6.823

9.  High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.

Authors:  Elizabeth A White; Karl Münger; Peter M Howley
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  51 in total

1.  Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.

Authors:  Irene Lo Cigno; Federica Calati; Cinzia Borgogna; Alessandra Zevini; Silvia Albertini; Licia Martuscelli; Marco De Andrea; John Hiscott; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

2.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

3.  DAMP-driven metabolic adaptation.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-01       Impact factor: 53.106

4.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

5.  Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.

Authors:  Tingting Qin; Lada A Koneva; Yidan Liu; Yanxiao Zhang; Anna E Arthur; Katie R Zarins; Thomas E Carey; Douglas Chepeha; Gregory T Wolf; Laura S Rozek; Maureen A Sartor
Journal:  Head Neck       Date:  2020-05-14       Impact factor: 3.147

6.  A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.

Authors:  Yuan-Qin Min; Yun-Jia Ning; Hualin Wang; Fei Deng
Journal:  J Biol Chem       Date:  2020-05-29       Impact factor: 5.157

7.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 8.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

9.  USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis.

Authors:  Junnosuke Nakamura; Chiharu Hamada; Takumi Taketomi; Jaehyun Kim; Sarasa Yano; Tomomi Okajima; Shin-Ichi Kashiwabara; Tadashi Baba; Ban Sato; Tomoki Chiba; Fuminori Tsuruta
Journal:  Mol Cell Biol       Date:  2020-10-13       Impact factor: 4.272

10.  Identification of HPV16-p16INK4a mediated methylation in oral potentially malignant disorder.

Authors:  Maria Rosa Buenahora; Gloria Inés Lafaurie; Sandra J Perdomo
Journal:  Epigenetics       Date:  2020-11-09       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.